Sanofi gets drug regulator nod to market RSV therapy in India
3 months ago•Economic Times
Sanofi gets regulatory nod for RSV product in India
3 months ago•The Hindu Businessline
Sanofi India stock falls 2% on weak June quarter results; profit falls 16%
3 months ago•Business Standard
Sanofi India standalone net profit declines 15.87% in the June 2024 quarter
3 months ago•Business Standard
Sanofi India Ltd spurts 1.9%, rises for fifth straight session
3 months ago•Business Standard
Sanofi Initiates Voluntary Recall Of Allegra, Combiflam Suspensions In India Over Contamination Concerns - News18
3 months ago•News18
Sanofi Stocks: Company To Collaborate With Hyderabad GCC, What’s The Expansion plan In India?
3 months ago•ET NOW